AbbVie
-
Health
AbbVie signs $10 bln deal to buy cancer drugmaker ImmunoGen, Health News, ET HealthWorld
New Delhi: AbbVie said on Thursday it will buy ImmunoGen for $10.1 billion, underscoring a growing interest from large drugmakers…
Read More » -
Business
AbbVie to Buy ImmunoGen for More Than $10 Billion
AbbVie has agreed to buy ImmunoGen for about $10.1 billion in a deal that speeds the biopharmaceutical company’s entry into…
Read More » -
Business
US money managers say stocks look more attractive in the long term
Patience in a volatile market like this year is a tall order. But it is a recipe for long-term success…
Read More » -
Business
Lack of optimism for Alzheimer’s treatment means little is left to lose
Companies looking for a treatment for Alzheimer’s have spent a staggering amount of money in recent decades with little to…
Read More » -
Business
The stock market is the heaviest, but the carnage is widespread
Eight companies are responsible for nearly half of this year’s stock market plunge – and the pain doesn’t end there.…
Read More »